Bio-Rad Laboratories, Inc. (BIO.B) stock
BIO.BNYSELaboratory Analytical InstrumentsFiscal year ends December 31Also trades as BIO
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026Score 8/3055% above fair value
$379.50+0.00 (0.00%)
Close on Oct 29, 2026Market cap $10.18BP/E 46.2Yield –
Bio-Rad Laboratories ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Bio-Rad Laboratories's ebitda for the twelve months ending Mar 31, 2020 was $382.33M, up 725.4% year over year. For fiscal 2025 it was $212.60M, down 49.5% from the year before. Over ten years it grew -3.3% a year on average. The highest annual figure on record is $637.94M in fiscal 2021.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $212.60M | -49.5% |
| FY2024 | Dec 31, 2024 | $420.60M | -13.0% |
| FY2023 | Dec 31, 2023 | $483.70M | -22.0% |
| FY2022 | Dec 31, 2022 | $619.90M | -2.8% |
| FY2021 | Dec 31, 2021 | $637.94M | +13.9% |
| FY2020 | Dec 31, 2020 | $559.93M | +53.9% |
| FY2019 | Dec 31, 2019 | $363.86M | +946.8% |
| FY2018 | Dec 31, 2018 | $34.76M | -87.0% |
| FY2017 | Dec 31, 2017 | $267.95M | +34.9% |
| FY2016 | Dec 31, 2016 | $198.62M | -33.5% |
| FY2015 | Dec 31, 2015 | $298.51M | -0.5% |
| FY2014 | Dec 31, 2014 | $299.88M | -5.3% |
| FY2013 | Dec 31, 2013 | $316.66M | -19.7% |
| FY2012 | Dec 31, 2012 | $394.58M | -7.4% |
| FY2011 | Dec 31, 2011 | $426.24M | +8.5% |
| FY2010 | Dec 31, 2010 | $392.91M | +18.1% |
| FY2009 | Dec 31, 2009 | $332.69M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2020 | Mar 31, 2020 | $107.97M | +20.6% |
| Q4 FY2019 | Dec 31, 2019 | $93.61M | – |
| Q3 FY2019 | Sep 30, 2019 | $91.16M | +28.1% |
| Q2 FY2019 | Jun 30, 2019 | $89.59M | +14.6% |
| Q1 FY2019 | Mar 31, 2019 | $89.51M | +14.8% |
| Q4 FY2018 | Dec 31, 2018 | -$192.55M | -317.3% |
| Q3 FY2018 | Sep 30, 2018 | $71.18M | -3.9% |
| Q2 FY2018 | Jun 30, 2018 | $78.19M | +121.5% |
| Q1 FY2018 | Mar 31, 2018 | $77.95M | +30.1% |
| Q4 FY2017 | Dec 31, 2017 | $88.60M | +1849.8% |
| Q3 FY2017 | Sep 30, 2017 | $74.06M | +21.0% |
| Q2 FY2017 | Jun 30, 2017 | $35.30M | – |
| Q1 FY2017 | Mar 31, 2017 | $59.91M | – |
| Q4 FY2016 | Dec 31, 2016 | $4.54M | – |
| Q3 FY2016 | Sep 30, 2016 | $61.19M | – |